These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The risk of neuroleptic discontinuation in schizophrenia]. Jarema M Psychiatr Pol; 1999; 33(1):69-81. PubMed ID: 10786216 [TBL] [Abstract][Full Text] [Related]
25. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal. Llorca PM; Vaiva G; Lancon C Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497 [No Abstract] [Full Text] [Related]
26. Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come. Meltzer HY Arch Gen Psychiatry; 1995 Mar; 52(3):200-2. PubMed ID: 7872845 [No Abstract] [Full Text] [Related]
27. Neuroleptic withdrawal in schizophrenic patients. Baldessarini RJ; Viguera AC Arch Gen Psychiatry; 1995 Mar; 52(3):189-92. PubMed ID: 7872842 [No Abstract] [Full Text] [Related]
28. Ziprasidone-associated depressive state in schizophrenic patients. Kaptsan A; Dwolatzky T; Lerner V Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461 [TBL] [Abstract][Full Text] [Related]
29. Stopping drug treatment in schizophrenia. Drug Ther Bull; 1987 Apr; 25(8):31-2. PubMed ID: 2884089 [No Abstract] [Full Text] [Related]
30. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome. Ingole A; Bastiampillai T; Tibrewal P Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884 [No Abstract] [Full Text] [Related]
31. Tardive dyskinesia as a risk factor for negative symptoms. Wright P; Taylor M Br J Psychiatry; 1994 May; 164(5):700-1; author reply 702. PubMed ID: 7921731 [No Abstract] [Full Text] [Related]
32. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation. Mendhekar DN; Jiloha RC Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023 [No Abstract] [Full Text] [Related]